Pillar Pharmaceuticals 6 L.P. 13D and 13G filings for Aceragen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-03 4:59 pm Sale | 2023-07-21 | 13D | Aceragen, Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 81,187 1.000% | -655,295 (-88.98%) | Filing |
| 2023-07-17 07:30 am Sale | 2023-07-13 | 13D | Aceragen, Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 736,482 8.700% | -92,639 (-11.17%) | Filing |
| 2023-04-10 4:40 pm Sale | 2023-04-07 | 13D | Aceragen, Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 829,121 9.500% | -178,795 (-17.74%) | Filing |
| 2023-01-30 4:30 pm Purchase | 2023-01-17 | 13D | Aceragen, Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 1,007,916 11.350% | 1,007,916 (New Position) | Filing |